This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Mediterranean Society of Oncology | |
|---|---|
| Name | Mediterranean Society of Oncology |
| Abbreviation | MSO |
| Formation | 1990s |
| Type | Professional association |
| Headquarters | Mediterranean region |
| Region served | Mediterranean Basin |
| Leader title | President |
Mediterranean Society of Oncology is a regional professional association focused on cancer research, clinical oncology, and multidisciplinary care across the Mediterranean Basin, engaging clinicians, researchers, institutions, and policymakers from Europe, North Africa, and the Near East. The society fosters collaboration among centers in cities such as Barcelona, Milan, Athens, Istanbul, Cairo, Tel Aviv, Tunis, Algiers, Tripoli, and Valletta, promoting scientific exchange between members affiliated with institutions like Institut Curie, Istituto Nazionale dei Tumori, Hospital Clínic de Barcelona, Karolinska Institute, Weizmann Institute of Science, Ain Shams University, University of Barcelona, Sapienza University of Rome, and University of Athens.
The society emerged during a period of expanding international oncology networks influenced by initiatives from World Health Organization, Union for International Cancer Control, European Society for Medical Oncology, and national academies including the Academia Europaea and Royal Society of Medicine. Founding meetings included delegations from centers such as University of Padua, University of Naples Federico II, Hebrew University of Jerusalem, American University of Beirut, University of Algiers, University of Tunis El Manar, University of Malta, University of Granada, Universidad Autónoma de Madrid, Université de Montpellier, Université Paris Cité, and University of Coimbra. Early leaders had prior roles in institutions like National Cancer Institute (US), Institut Gustave Roussy, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Johns Hopkins University, MD Anderson Cancer Center, and partnerships with bodies such as European Commission, Council of Europe, and Mediterranean Union influenced agenda-setting. Milestones included memoranda involving UNESCO, regional workshops held near Barcelona, conferences convened in Rome and Athens, and collaborations with registries such as IARC and national cancer registries in Spain, Italy, Greece, Turkey, Israel, Egypt, and Tunisia.
The society’s mission aligns with global priorities advanced by WHO and UICC to reduce cancer burden, improve outcomes, and harmonize standards across the Mediterranean, working alongside organizations such as European Commission, Council of Europe, Union for the Mediterranean, and national ministries including Ministry of Health (Italy), Ministry of Health (Spain), Ministry of Health (Greece), and Ministry of Health (Turkey). Objectives emphasize capacity building with partners like European Society for Medical Oncology, European Society of Surgical Oncology, American Society of Clinical Oncology, International Agency for Research on Cancer, and academic centers such as Imperial College London, University College London, University of Oxford, Harvard Medical School, Yale School of Medicine, and University of Cambridge. The society promotes guidelines harmonization referencing frameworks from NICE, European Medicines Agency, Food and Drug Administration, European Cancer Organisation, and clinical trial cooperation consistent with regulations of European Union member states and regional authorities.
Governance includes an elected council, executive board, scientific committee, and advisory panels drawing experts from institutions like Institut Curie, Istituto Europeo di Oncologia, Barcelona Clinic Oncology Department, National Cancer Institute (Italy), Helsinki University Hospital, Sheba Medical Center, Coptic Orthodox Church (contextual institutional stakeholders), and representatives from national societies such as Italian Association of Medical Oncology, Spanish Society of Medical Oncology, Hellenic Society of Medical Oncology, Turkish Society of Medical Oncology, Israeli Society of Clinical Oncology, Tunisian Society of Oncology, and Algerian Society of Oncology. Committees coordinate ethics and regulatory affairs in line with guidance from Declaration of Helsinki and engage legal advisers versed in instruments like European Convention on Human Rights and national statutes. The presidency rotates among members from Mediterranean states to reflect diversity comparable to rotating presidencies in bodies like European Union institutions.
Membership comprises oncologists, surgeons, radiation oncologists, pathologists, epidemiologists, nurses, and allied professionals affiliated with universities and hospitals including University of Barcelona, Sapienza University of Rome, Ain Shams University, Alexandria University, King’s College London, Cairo University, American University of Beirut, Saint Joseph University (Beirut), University of Tunis El Manar, University of Algiers 1, and University of Malta. Regional chapters operate in national contexts similar to chapters of American Society of Clinical Oncology, with hubs in Barcelona, Rome, Athens, Istanbul, Beirut, Cairo, Tunis, and Lisbon, liaising with national cancer registries, universities, and hospitals such as Hospital del Mar, Policlinico di Milano, Evangelismos Hospital, Istanbul University Cerrahpaşa, Rafik Hariri University Hospital, and Valletta General Hospital.
Programs include training fellowships modeled on exchanges like Fulbright Program and research grants comparable to awards from European Research Council, fellowships coordinated with institutions such as King’s College London and Imperial College London, and public health initiatives paralleling efforts by WHO and UNICEF in vaccination and screening. Educational activities encompass multidisciplinary tumor boards, surgical workshops with partners like American College of Surgeons and Society of Surgical Oncology, radiotherapy training referencing standards from European Society for Radiotherapy and Oncology, nursing development with International Council of Nurses, and survivorship programs aligned with practices from National Cancer Survivorship Initiative.
The society facilitates collaborative clinical trials and epidemiological studies in conjunction with IARC, European Clinical Trials Alliance, and national research councils, publishing proceedings, consensus statements, and position papers with authors from Institut Gustave Roussy, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Karolinska Institute, Weizmann Institute of Science, University of Barcelona, Sapienza University of Rome, Ain Shams University, and American University of Beirut. It supports registries interoperable with datasets from SEER Program, European Cancer Information System, and national registries in Spain, Italy, Greece, Turkey, and Israel. Publications appear in journals such as The Lancet Oncology, Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Cancer Cell, and specialist regional supplements.
Annual and biennial meetings convene clinicians and scientists similar in scope to gatherings hosted by ESMO, ASCO, AACR Annual Meeting, SNO Annual Meeting, and EACR; venues have included cities like Barcelona, Rome, Athens, Istanbul, Beirut, Cairo, and Valletta. Events feature keynote lectures from leaders associated with Nobel Prize-winning labs, plenary sessions mirroring topics at World Cancer Congress, poster sessions, workshops, and satellite symposia co-sponsored by professional bodies such as European Society for Medical Oncology, American Society of Clinical Oncology, International Society of Paediatric Oncology, European Society for Radiotherapy and Oncology, and industry partners with compliance to regulations from European Medicines Agency and national health ministries.
Category:Oncology organizations